These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17033445)

  • 21. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
    Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
    Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype distribution among intravenous drug users with chronic type C hepatitis in southern Spain.
    García F; Roldán C; García F; Hernández J; García-Valdecasas J; Bernal MC; Piédrola G; Maroto MC
    Microbios; 1998; 95(380):15-24. PubMed ID: 9881460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users.
    Lin CL; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
    J Med Virol; 2007 Nov; 79(11):1674-8. PubMed ID: 17854041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
    Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccination and injecting drug users.
    Budd J; Robertson R; Elton R
    Br J Gen Pract; 2004 Jun; 54(503):444-7. PubMed ID: 15186567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z; Gorisek JR; Poljak M; Pisec A
    Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Karatapanis S; Skorda L; Marinopoulos S; Papastergiou V; Drogosi M; Lisgos P; Antsaklis A
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):878-83. PubMed ID: 22588307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccination awareness and biological risk.
    Trevisan A; Borella Venturini M; Paruzzolo P; Maso S
    Med Lav; 2002; 93(4):318-21. PubMed ID: 12212400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
    Ferreira RC; Rodrigues FP; Teles SA; Lopes CL; Motta-Castro AR; Novais AC; Souto FJ; Martins RM
    J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou].
    Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
    Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
    Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
    Achakzai M; Kassi M; Kasi PM
    Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.